Products
Online Inquiry
119-23
Cat. No.:
OB0626WX-3705
Appearance:
Liquid
Purity:
≥95%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
119-23 is an ionizable crystalline lipid engineered as a high-performance structural core for fabricating advanced lipid nanoparticle systems. This ionizable framework delivers superior intramuscular transfection efficiency and achieves significantly greater accumulation within visceral immune cells compared to standard benchmark ionizable lipids like SM-102 or DLin-MC3-DMA. When utilized to encapsulate therapeutic transcripts, the resulting lipid matrix optimizes endosomal escape to drive a powerful increase in circulating serum protein expression.
Synonyms:
9Z-octadecenoic acid, 6-[[3-(dimethylamino)propyl][(9Z)-1-oxo-9-octadecen-1-yl]amino]-7-oxo-7-(tricyclo[3.3.1.13,7]dec-1-ylamino)heptyl ester; 7-(adamantan-1-ylamino)-6-(N-(3-(dimethylamino)propyl)oleamido)-7-oxoheptyl oleate; 2953044-98-7
CAS No.:
2953044-98-7
Compound CID:
168976004
Formula:
C58H105N3O4
Formula Weight:
908.5
Specification
Solubility in Ethanol:
1-10 mg/mL
Solubility in Other Solvents:
Chloroform: 1-10 mg/mL
Storage:
Storage at -20°C.
Applications:
119-23 is utilized in lipid-based delivery research for investigating functional lipid components and formulation parameters. It supports studies of lipid composition, nanoparticle engineering, and characterization of lipid materials used in delivery systems.
